Immunotherapy and biomarker-driven agents are transforming care among patients with upper GI cancers. Maximizing the benefits of these new approaches requires both identifying appropriate patients and ensuring adverse effects are managed swiftly. Tune in to this on-demand video as a leading expert in upper GI cancers explores evidence-based recommendations for biomarker testing, guideline-aligned treatment selection and sequencing of novel therapies, and strategies for optimizing care for patients with upper GI cancers amid the unique challenges facing rural and underserved populations. For information on how this activity fits in the Royal College of Physicians and Surgeons of Canada Maintenance of Certification (MOC) Program, please visit the Royal College’s website.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/improving-upper-gi-cancer-care-community-oncology-settings-nationwide
- Start Date: 2024-11-29 06:00:00
- End Date: 2024-11-29 06:00:00
- Credit Details: IPCE Credits: 1.0 hours
AAPA Category 1 Credit™️: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
- Commercial Support: Source: Bristol-Myers Squibb Company - Amount: 112500.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence, Learner/Team Performance
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Medical Oncology